Contract Research Organization (CRO) Mass Spectroscopy Services Market Report 2026

The contract research organization (cro) mass spectroscopy services market size has grown rapidly in recent years. It will grow from $1.81 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to growth in pharmaceutical and biopharmaceutical R&D activity, increased reliance on CRO analytical services, expansion of biomarker discovery research, adoption of mass spectrometry in drug metabolism studies, rising demand for environmental and food testing.

The contract research organization (cro) mass spectroscopy services market size is expected to see rapid growth in the next few years. It will grow to $3.32 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing investments in precision medicine research, rising complexity of biologics and cell therapies, growing demand for multi-omics analysis, expansion of clinical proteomics applications, increased outsourcing of advanced analytical workflows. Major trends in the forecast period include increasing demand for high-resolution mass spectrometry services, growing adoption of outsourced proteomics and metabolomics analysis, expansion of bioanalytical method development services, rising use of advanced data analytics in spectral interpretation, enhanced focus on regulatory-compliant analytical testing.

The expanding pharmaceutical and biotechnology sectors are expected to drive the growth of the contract research organization (CRO) mass spectrometry services market going forward. The pharmaceutical and biotechnology industries consist of organizations involved in the discovery, development, and production of drugs, biologics, and diagnostics aimed at improving patient health outcomes. These industries are growing due to increasing investments in research and development, which fuel the creation of new drugs and therapies to address complex and unmet medical needs. Contract research organization (CRO) mass spectrometry services support the pharmaceutical and biotechnology sectors by delivering precise analytical insights that accelerate drug discovery, development, and regulatory compliance. For instance, in April 2024, according to Eurostat, the Luxembourg-based official statistical agency of the European Union, imports of medicinal and pharmaceutical products into the EU rose by 6.1% in 2023, reaching 137.4 billion USD (€119 billion) compared to the previous year. During the same period, EU exports totaled 319.2 billion USD (€277 billion), resulting in a trade surplus of 182 billion USD (€158 billion). Therefore, the growing pharmaceutical and biotechnology sectors are propelling the growth of the contract research organization (CRO) mass spectrometry services market.

Major companies operating in the contract research organization (CRO) mass spectrometry services market are focusing on developing advanced technological platforms, such as next-generation mass spectrometry (MS) software solutions, to enhance biomarker discovery, protein quantification, and immunopeptidomics analysis. Next-generation mass spectrometry (MS) software solutions are advanced tools designed to improve the speed, accuracy, and efficiency of data analysis in complex chemical and biological research. For instance, in May 2025, Biognosys AG, a Switzerland-based mass spectrometry solutions company, launched Spectronaut 20 and SpectroMine 5, two cutting-edge MS data analysis platforms that set new standards in immunopeptidomics and data-independent acquisition (DIA) workflows. These AI-enhanced platforms significantly increase sensitivity and accuracy in detecting low-abundance peptides, providing unparalleled proteome coverage and neoantigen identification. By replacing manual, error-prone data interpretation with automated, machine learning-driven analytics, these solutions enable researchers to accelerate therapeutic target validation. Key features include an enhanced peptide-spectrum matching engine, which improves peptide identification rates and quantification consistency, ensuring more reliable and reproducible results in clinical research applications.

In March 2025, Momentum Biotechnologies, a US-based contract research organization, acquired OmicScouts GmbH for an undisclosed amount. Through this acquisition, Momentum Biotechnologies aims to expand its mass spectrometry-based drug discovery capabilities and strengthen its presence in the European market. OmicScouts GmbH is a Germany-based CRO specializing in mass spectrometry-based proteomics and chemoproteomics services.

Major companies operating in the contract research organization (cro) mass spectroscopy services market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, ICON Public Limited Company, Eurofins Scientific SE, Charles River Laboratories International Inc., Medpace Holdings Inc., Novatia LLC, Inotiv Inc., BioAgilytix Labs LLC, Altasciences Company Inc., ABC Laboratories Inc., Omics Solutions LLC, Creative Proteomics Inc., Momentum Biotechnologies LLC, Accurant Biotech Inc., Alderley Analytical Limited, Allumiqs Corporation, CovalX AG, MS Bioworks LLC, Frontage Laboratories Inc., PPD Laboratories, WuXi AppTec Co. Ltd.

North America was the largest region in the contract research organization (CRO) mass spectroscopy services market in 2025. The regions covered in the contract research organization (cro) mass spectroscopy services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the contract research organization (cro) mass spectroscopy services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the CRO mass spectroscopy services market by increasing costs of imported mass spectrometers, detectors, vacuum systems, reagents, and high-precision electronic components. Service providers in North America and Europe are most affected due to reliance on imported analytical instruments, while Asia-Pacific faces higher capital costs for laboratory expansion. These tariffs are raising service pricing and delaying equipment upgrades. However, they are also supporting regional instrument servicing, localized consumables production, and increased collaboration with domestic equipment manufacturers.

The contract research organization (cro) mass spectroscopy services market research report is one of a series of new reports that provides contract research organization (cro) mass spectroscopy services market statistics, including contract research organization (cro) mass spectroscopy services industry global market size, regional shares, competitors with a contract research organization (cro) mass spectroscopy services market share, detailed contract research organization (cro) mass spectroscopy services market segments, market trends and opportunities, and any further data you may need to thrive in the contract research organization (cro) mass spectroscopy services industry. This contract research organization (cro) mass spectroscopy services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Contract research organization (CRO) mass spectrometry services refer to specialized analytical testing offered by third-party research organizations that use mass spectrometry technology to support drug development, clinical research, environmental analysis, and other scientific applications. These services involve the identification, quantification, and structural characterization of chemical compounds, biomolecules, and complex mixtures using techniques and high-resolution mass spectrometry.

The primary types of contract research organization (CRO) mass spectrometry services include proteomics services, metabolomics services, and others. Proteomics services involve mass spectrometry analyses that profile proteins in biological samples, tracking their identity, abundance, modifications, and interactions. These services are applied across various areas, including drug discovery and development, clinical research, preclinical testing, environmental testing, forensic testing, food safety analysis, and proteomics and genomics research, serving end users such as pharmaceutical and biopharmaceutical companies, medical device companies, and others.

The contract research organization (CRO) mass spectroscopy services market consists of revenues earned by entities by providing services such as biomarker discovery and validation, quality control and stability testing, and clinical sample analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.